{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:07:33Z","timestamp":1760188053790,"version":"3.33.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1136\/ard.60.10.984a","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:37:40Z","timestamp":1027766260000},"page":"984-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fenofibrate: a new treatment for hyperuricaemia and gout?"],"prefix":"10.1016","volume":"60","author":[{"given":"A L","family":"HEPBURN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"KAYE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M D","family":"FEHER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.60.10.984a_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/j.1552-4604.1980.tb01670.x","article-title":"Uricosuric effect of fenofibrate in healthy volunteers.","volume":"20","author":"Desager","year":"1980","journal-title":"J Clin Pharmacol"},{"key":"10.1136\/ard.60.10.984a_bib2","first-page":"73","article-title":"Hypolipidaemic and hypouricaemic action of fenofibrate in various types of hyperlipoproteinaemia.","volume":"7","author":"Harvengt","year":"1980","journal-title":"Artery"},{"key":"10.1136\/ard.60.10.984a_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0026-0495(88)90098-4","article-title":"Hypertriglyceridaemia and hyperuricaemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind placebo-controlled trial.","volume":"37","author":"Bastow","year":"1988","journal-title":"Metabolism"},{"key":"10.1136\/ard.60.10.984a_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<395::AID-DMRR65>3.0.CO;2-N","article-title":"Atherogenic lipoprotein phenotype in type 2 diabetes: reversal with micronised fenofibrate.","volume":"15","author":"Feher","year":"1999","journal-title":"Diabetes Metab Rev"},{"key":"10.1136\/ard.60.10.984a_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0026-0495(85)90025-3","article-title":"Hyperuricaemia and hypertriglyceridaemia: metabolic basis for the association.","volume":"34","author":"Fox","year":"1985","journal-title":"Metabolism"},{"key":"10.1136\/ard.60.10.984a_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/ard.57.9.509","article-title":"Hyperlipidaemia in hyperuricaemia and gout.","volume":"57","author":"Emmerson","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.10.984a_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.1964.03070220062023","article-title":"Blood lipid and uric acid interrelationships.","volume":"190","author":"Berkowitz","year":"1964","journal-title":"JAMA"},{"key":"10.1136\/ard.60.10.984a_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.CIR.29.4.508","article-title":"Hypertriglyceridaemia in gout.","volume":"29","author":"Feldman","year":"1964","journal-title":"Circulation"},{"key":"10.1136\/ard.60.10.984a_bib9","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality. The NHANES 1\/epidemiologic follow-up study 1971\u201392.","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1136\/ard.60.10.984a_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1047-2797(99)00037-X","article-title":"Serum uric acid and the risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study.","volume":"10","author":"Moriarity","year":"2000","journal-title":"Ann Epidemiol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724433700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724433700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.60.10.984a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:56:50Z","timestamp":1737359810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724433700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0003496724433700"],"URL":"https:\/\/doi.org\/10.1136\/ard.60.10.984a","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate: a new treatment for hyperuricaemia and gout?","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.60.10.984a","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}